García-García Angeles, Gálvez Jorge, de Julián-Ortiz Jesus Vicente, García-Domenech Ramón, Muñoz Carlos, Guna Remedios, Borrás Rafael
Unidad de Investigación de Diseño de Fármacos y Conectividad Molecular, Departamento de Química Física, Facultad de Farmacia, Universitat de València, Av. Vicent Andrés Estellés s/n, 46100 Burjassot, Spain.
J Biomol Screen. 2005 Apr;10(3):206-14. doi: 10.1177/1087057104273486.
A method to identify chemical scaffolds potentially active against Mycobacterium tuberculosis is presented. The molecular features of a set of structurally heterogeneous antituberculosis drugs were coded by means of structural invariants. Three techniques were used to obtain equations able to model the antituberculosis activity: linear discriminant analysis, multilinear regression, and shrinkage estimation-ridge regression. The model obtained was statistically validated through leave-n-out test, and an external set and was applied to a database for the search of new active agents. The selected compounds were assayed in vitro, and among those identified as active stand reserpine, N,N,N',N'-tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN), trifluoperazine, pentamidine, and 2-methyl-4,6-dinitro-phenol (DNOC). They show activity comparable to or superior to ethambutol, used in combination with other drugs for the prevention and treatment of Mycobacterium avium complex and drug-resistant tuberculosis.
本文介绍了一种鉴定可能对结核分枝杆菌具有活性的化学骨架的方法。通过结构不变量对一组结构异质的抗结核药物的分子特征进行编码。使用了三种技术来获得能够对抗结核活性进行建模的方程:线性判别分析、多元线性回归和收缩估计-岭回归。通过留一法检验对所得模型进行了统计学验证,并应用于一个外部数据集,以搜索新的活性剂。对所选化合物进行了体外测定,鉴定为活性的化合物包括利血平、N,N,N',N'-四-(2-吡啶甲基)-乙二胺(TPEN)、三氟拉嗪、喷他脒和2-甲基-4,6-二硝基苯酚(DNOC)。它们显示出与乙胺丁醇相当或优于乙胺丁醇的活性,乙胺丁醇与其他药物联合用于预防和治疗鸟分枝杆菌复合体和耐多药结核病。